首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2017年 7期肝癌的诊断和非手术治疗 => 专家论坛 =>肝细胞癌的血清学诊断..
肝细胞癌的血清学诊断—挑战与希望同在
Serological diagnosis of hepatocellular carcinoma: challenges and opportunities
文章发布日期:2017年06月07日  来源:  作者:鲁凤民  点击次数:1224次  下载次数:234次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:血清学指标因无创和操作简易的特点一直是肝细胞癌诊断的研究热点。简要介绍了传统血清学指标AFP在HBV感染相关肝癌辅助诊断和预后预测中的应用。评述了甲胎蛋白异质体(AFP-L3)和异常凝血酶原/脱-γ-羧基凝血酶原(DCP)等新指标的临床应用价值。通过一系列的文献回顾对血清高尔基体蛋白73(GP73)作为肝癌实验室辅助诊断的可能性提出质疑,并依据笔者的实验结果,提出了血清GP73测定或可作为进展期肝纤维化和肝硬化的实验室诊断指标的建议。
【Abstract】:Serological markers have the features of noninvasiveness and simple operation and thus have become a research hotspot in the diagnosis of hepatocellular carcinoma. This article briefly introduces the role of the conventional serological marker alpha-fetoprotein (AFP) in assisting the diagnosis and predicting the prognosis of HBV-related liver cancer, as well as the clinical value of new markers such as alpha-fetoprotein-L3 and abnormal prothrombin/des-γ-carboxy prothrombin. Based on literature review, the possibility of serum Golgi protein 73 used for laboratory auxiliary diagnosis of hepatocellular carcinoma has been denied. The results of the author′s experiment suggest that serum GP73 measurement can be used as a laboratory diagnostic index for progressive liver fibrosis and liver cirrhosis.
【关键字】:癌, 肝细胞; 肝硬化; 甲胎蛋白类; 甲胎蛋白异质体; 异常凝血酶原; 高尔基体蛋白73
【Key words】:carcinoma, hepatocellular; liver cirrhosis; alpha-fetoproteins; alpha-fetoprotein-L3; des-gamma-carboxynprothrombin; Golgi protein 73
【引证本文】:鲁凤民. 肝细胞癌的血清学诊断——挑战与希望同在[J]. 临床肝胆病杂志, 2017, 33(7): 1262-1265.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号